On June 16, 2026 (Tuesday), from 3:00 p.m. JST, our Chief Innovation Officer (CIO), Ogawa, will speak at a webinar hosted by Illumina K.K. The presentation will be delivered in Japanese.

Ogawa will give a talk entitled “Cutting-edge AI Antibody Discovery: Case Studies of Ultra-high-performance Antibody Exploration Utilizing NGS and Large Language Models” (English translation of the original Japanese title). In this webinar, he will introduce the forefront of AI-driven antibody drug discovery, highlighting case studies in which MOLCURE combined its proprietary AI technologies with Illumina’s next-generation sequencers (NGS) to discover high-performance antibodies.

The webinar will be held online only and is free of charge, with prior registration required. For more details and registration, please visit the official event page.